BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38082335)

  • 1. Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives.
    Zhou Y; Xu Z; Liu Z
    J Transl Med; 2023 Dec; 21(1):902. PubMed ID: 38082335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
    Cayrol C; Girard JP
    Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-33 Mediated Inflammation in Chronic Respiratory Diseases-Understanding the Role of the Member of IL-1 Superfamily.
    Gabryelska A; Kuna P; Antczak A; Białasiewicz P; Panek M
    Front Immunol; 2019; 10():692. PubMed ID: 31057533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33/ST2 Axis in Organ Fibrosis.
    Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
    Front Immunol; 2018; 9():2432. PubMed ID: 30405626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conflicting vascular and metabolic impact of the IL-33/sST2 axis.
    Altara R; Ghali R; Mallat Z; Cataliotti A; Booz GW; Zouein FA
    Cardiovasc Res; 2018 Oct; 114(12):1578-1594. PubMed ID: 29982301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
    Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
    Front Immunol; 2018; 9():2004. PubMed ID: 30233590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice.
    Wu H; Yang S; Wu X; Zhao J; Zhao J; Ning Q; Xu Y; Xie J
    Biochem Biophys Res Commun; 2014 Jul; 450(1):110-6. PubMed ID: 24866242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the IL-33-ST2 axis in sepsis.
    Xu H; Turnquist HR; Hoffman R; Billiar TR
    Mil Med Res; 2017; 4():3. PubMed ID: 28168040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
    Chen WY; Li LC; Yang JL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
    Cayrol C; Girard JP
    Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention.
    Saikumar Jayalatha AK; Hesse L; Ketelaar ME; Koppelman GH; Nawijn MC
    Pharmacol Ther; 2021 Sep; 225():107847. PubMed ID: 33819560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
    Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
    Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33 mediates inflammatory responses in human lung tissue cells.
    Yagami A; Orihara K; Morita H; Futamura K; Hashimoto N; Matsumoto K; Saito H; Matsuda A
    J Immunol; 2010 Nov; 185(10):5743-50. PubMed ID: 20926795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of IL-33 in Non-hematopoietic Lung Cells to Obstructive Lung Disease.
    Drake LY; Prakash YS
    Front Immunol; 2020; 11():1798. PubMed ID: 32903501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms Underlying IL-33-Mediated Inflammation in Inflammatory Bowel Disease.
    Aggeletopoulou I; Tsounis EP; Triantos C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-33/ST2 pathway is not essential to Th2 stimulation but is key for modulation and survival during chronic infection with Schistosoma mansoni in mice.
    Maggi L; Rocha IC; Camelo GMA; Fernandes VR; Negrão-Corrêa D
    Cytokine; 2021 Feb; 138():155390. PubMed ID: 33341001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
    Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
    World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhinovirus-induces progression of lung disease in a mouse model of COPD via IL-33/ST2 signaling axis.
    Gimenes JA; Srivastava V; ReddyVari H; Kotnala S; Mishra R; Farazuddin M; Li W; Sajjan US
    Clin Sci (Lond); 2019 Apr; 133(8):983-996. PubMed ID: 30952808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidised IL-33 drives COPD epithelial pathogenesis
    Strickson S; Houslay KF; Negri VA; Ohne Y; Ottosson T; Dodd RB; Huntington CC; Baker T; Li J; Stephenson KE; O'Connor AJ; Sagawe JS; Killick H; Moore T; Rees DG; Koch S; Sanden C; Wang Y; Gubbins E; Ghaedi M; Kolbeck R; Saumyaa S; Erjefält JS; Sims GP; Humbles AA; Scott IC; Romero Ros X; Cohen ES
    Eur Respir J; 2023 Sep; 62(3):. PubMed ID: 37442582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.